A good year for women on film, as exemplified in new releases The Eyes of My Mother, Miss Sloane, and more
Matthew Lickona 5 p.m., Dec. 9
Corporate raider Carl Icahn this afternoon (June 3) said he has won two of 13 total seats on the board of Cambridge, Massachusetts-based biotech Biogen Idec. The Idec part of the company has been one of San Diego's biotech success stories. At last report, Biogen Idec was saying shareholders need more time to vote. Icahn's representatives have objected. Last year, Icahn waged a proxy fight against Biogen Idec, wanting to sell the company. This year, he wants to break it into two separate businesses. On May 27, Icahn won a board seat on San Diego biotech Amylin. Another dissident group one a seat, too, on the 12-seat board.